4.8 Editorial Material

B cells to the forefront of immunotherapy

Journal

NATURE
Volume 577, Issue 7791, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/d41586-019-03943-0

Keywords

-

Funding

  1. NCI NIH HHS [P50 CA097190, P30 CA047904] Funding Source: Medline

Ask authors/readers for more resources

Three studies reveal that the presence in tumours of two key immune components - B cells and tertiary lymphoid structures - is associated with favourable outcomes when individuals undergo immunotherapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available